Extracellular Vesicles: Bridging the Heart and Tumor in Reverse Cardio-Oncology
- PMID: 38805582
- PMCID: PMC11141114
- DOI: 10.1161/CIRCULATIONAHA.124.069379
Extracellular Vesicles: Bridging the Heart and Tumor in Reverse Cardio-Oncology
Keywords: Editorials; cancer; cardio-oncology; cardiovascular disease; cytokines; extracellular vesicles.
Conflict of interest statement
Figures

Comment on
-
Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.Circulation. 2024 May 28;149(22):1729-1748. doi: 10.1161/CIRCULATIONAHA.123.066911. Epub 2024 Mar 15. Circulation. 2024. PMID: 38487879 Free PMC article.
Similar articles
-
[Heart and cancer: cardio-oncology].Herz. 2024 Mar;49(2):111-117. doi: 10.1007/s00059-024-05232-7. Epub 2024 Jan 30. Herz. 2024. PMID: 38289420 Review. German.
-
Reverse cardio-oncology: A budding concept.Indian Heart J. 2023 Nov-Dec;75(6):398-402. doi: 10.1016/j.ihj.2023.09.004. Epub 2023 Sep 27. Indian Heart J. 2023. PMID: 37774949 Free PMC article. Review.
-
Education in cardio-oncology: the next frontiers.Eur Heart J. 2024 Jul 12;45(27):2352-2354. doi: 10.1093/eurheartj/ehad895. Eur Heart J. 2024. PMID: 38845152 No abstract available.
-
Innovative therapeutic targets in cardio-oncology and a Great Debate in heart failure.Eur Heart J. 2024 Jul 9;45(25):2171-2174. doi: 10.1093/eurheartj/ehae397. Eur Heart J. 2024. PMID: 38979806 No abstract available.
-
The year in cardiovascular medicine 2023: the top 10 papers in cardio-oncology.Eur Heart J. 2024 Jul 9;45(25):2197-2200. doi: 10.1093/eurheartj/ehae194. Eur Heart J. 2024. PMID: 38591649 No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical